A Pilot Study of the Synergy between Two Antimicrobial Peptides and Two Common Antibiotics

Keyphrases

• Pseudomonas Aeruginosa (P. aeruginosa) 100%
• Antibiotics 100%
• Antimicrobial Peptides 100%
• Ciprofloxacin 75%
• Minimum Inhibitory Concentration 50%
• Staphylococcus Aureus 50%
• Fractional Inhibitory Concentration Index 50%
• Fluoroquinolones 50%
• Melimine 50%
• Antimicrobial 25%
• Microorganisms 25%
• Antibiotic Use 25%
• Antibiotic Resistance 25%
• Frequent Use 25%
• Cefepime 25%
• Resistant Strains 25%
• Novel Antimicrobials 25%
• Synergistic Activity 25%
• Protamine 25%
• Broth Dilution 25%
• Concentration Value 25%
• Mel4 25%
• Checkerboard Assay 25%
• Common Pathogens 25%
• Microtiter 25%
• Unrestricted Use 25%
• Treatment Line 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Pseudomonas aeruginosa 100%
• Antibiotics 100%
• Polypeptide Antibiotic Agent 100%
• Ciprofloxacin 75%
• Antiinfective Agent 50%
• Staphylococcus Aureus 50%
• Quinolone Derivative 50%
• Minimum Inhibitory Concentration 50%
• Adenosine Phosphate 50%
• Infection 25%
• Cefepime 25%
• Infectious Agent 25%
• Protamine 25%
• Microorganism 25%
• Antibiotic Resistance 25%
• Antimicrobial Agent 25%

Immunology and Microbiology

• Pseudomonas aeruginosa 100%
• Antimicrobial Peptides 100%
• Staphylococcus Aureus 50%
• Minimum Inhibitory Concentration 50%
• Inhibitory Concentration 50%
• Infectious Agent 25%
• Antimicrobial Resistance 25%
• Broth Dilution 25%
• Microorganism 25%
• Antimicrobial Agent 25%